FUNCTIONAL-CHARACTERIZATION OF 2 HUMAN SULFOTRANSFERASE CDNAS THAT ENCODE MONOAMINE-SULFATING AND PHENOL-SULFATING FORMS OF PHENOL SULFOTRANSFERASE - SUBSTRATE KINETICS, THERMAL-STABILITY AND INHIBITOR-SENSITIVITY STUDIES

被引:57
作者
VERONESE, ME
BURGESS, W
ZHU, XY
MCMANUS, ME
机构
[1] FLINDERS UNIV S AUSTRALIA,DEPT CLIN PHARMACOL,ADELAIDE,SA 5001,AUSTRALIA
[2] UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,ST LUCIA,QLD 4067,AUSTRALIA
关键词
D O I
10.1042/bj3020497
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present paper describes the functional characterization of two human aryl sulphotransferase (HAST) cDNAs, HAST1 and HAST3, previously isolated by us from liver and brain, respectively [Zhu, Veronese, Sansom, and McManus (1993) Biochem. Biophys. Res. Commun. 192, 671-676; Zhu, Veronese, Bernard, Sansom and McManus (1993) Biochem. Biophys. Res. Commun. 195, 120-127]. These appear to encode the two major forms of phenol sulphotransferase (PST) characterized in a number of human tissue cytosols, these being the phenolsulphating (P-PST) and monoamine-sulphating (M-PST) forms of phenol sulphotransferase. HAST1 and HAST3 cDNAs were functionally expressed in COS-7 cells and kinetically characterized using the model substrates for P-PST and M-PST, p-nitrophenol and dopamine (3,4-dihydroxyphenethylamine) respectively. COS-expressed HAST1 was shown to be enzymically active in sulphating p-nitrophenol with high affinity (K-m 0.6 mu M), whereas dopamine was the preferred substrate for HAST3 (K-m 9.7 mu M). HAST1 could also sulphate dopamine, as could HAST3 sulphate p-nitrophenol, but the K-m for these reactions were at least two orders of magnitude greater than for the preferred substrates. COS-expressed HAST1 and HAST3 displayed inhibition profiles with the ST inhibitor 2,6-dichloro-4-nitrophenol (DCNP), identical with human liver cytosolic P-PST and M-PST activities respectively. Thermal-stability studies with the expressed enzymes showed that HAST1 was considerably more thermostable (TS) than HAST3, which is consistent with P-PST being termed the TS PST and M-PST being termed the thermolabile (TL) PST. Western immunoblot analyses of the expressed PST proteins using an antibody generated to a bacterially expressed rat liver aryl/phenol ST showed that HAST1 and HAST3 migrated as single proteins with different electrophoretic mobilities (32 versus 34 kDa). This is consistent with the differences in electrophoretic mobilities observed for P-PST and M-PST in a variety of tissues reported by other workers. This report on the functional characterization of P-PST and M-PST cDNAs provides important information on the structural as well as functional relationships of human PSTs, which sulphate a vast array of exogenous and endogenous compounds.
引用
收藏
页码:497 / 502
页数:6
相关论文
共 21 条
[1]   HUMAN-LIVER PHENOL SULFOTRANSFERASE - ASSAY CONDITIONS, BIOCHEMICAL-PROPERTIES AND PARTIAL-PURIFICATION OF ISOZYMES OF THE THERMOSTABLE FORM [J].
CAMPBELL, NRC ;
VANLOON, JA ;
WEINSHILBOUM, RM .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (09) :1435-1446
[2]   CLONING AND EXPRESSION OF HUMAN LIVER DEHYDROEPIANDROSTERONE SULFOTRANSFERASE [J].
COMER, KA ;
FALANY, JL ;
FALANY, CN .
BIOCHEMICAL JOURNAL, 1993, 289 :233-240
[3]   CDNA EXPRESSION STUDIES OF RAT-LIVER ARYL SULFOTRANSFERASE [J].
CRUICKSHANK, D ;
SANSOM, LN ;
VERONESE, ME ;
MOJARRABI, B ;
MCMANUS, ME ;
ZHU, XY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (01) :295-301
[4]   MOLECULAR ENZYMOLOGY OF HUMAN LIVER CYTOSOLIC SULFOTRANSFERASES [J].
FALANY, CN .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (07) :255-259
[5]   PURIFICATION AND CHARACTERIZATION OF HUMAN LIVER PHENOL-SULFATING PHENOL SULFOTRANSFERASE [J].
FALANY, CN ;
VAZQUEZ, ME ;
HEROUX, JA ;
ROTH, JA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 278 (02) :312-318
[6]   RAT-BRAIN PHENOLSULFOTRANSFERASE-PARTIAL PURIFICATION AND SOME PROPERTIES [J].
FOLDES, A ;
MEEK, JL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 327 (02) :365-374
[7]  
HEROUX JA, 1989, MOL PHARMACOL, V36, P29
[8]  
HIRSHEY SJ, 1992, MOL PHARMACOL, V42, P257
[9]  
MCMANUS ME, 1987, MOL PHARMACOL, V32, P189
[10]  
Mulder G.J., 1990, CONJUGATION REACTION, P107